Article Name Clinical & Diagnostic
The oncology market in India is steadily growing, driven by an increasing cancer incidence and a strong demand for advanced treatments. However, there remains substantial untapped potential, primarily in improving access to cutting-edge therapies and expanding reach to underserved regions. Glenmark Pharma, with its patient-centric approach and innovative solutions, has been steadily increasing its market share by introducing high-quality and affordable cancer drugs. Alok Malik, President & Business Head - India Formulations, Glenmark Pharmaceuticals Ltd, in an exclusive interview with MedTech Spectrum & BioSpectrum, spoke at length about the company’s mission to enhance access to high-quality cancer care in India and the untapped market potential, new launches and the plans ahead.
28th February, 2024
The US Food and Drug Administration (FDA) approval in December 2023, of two milestone treatments, Casgevy and Lyfgenia, representing the first cell-based gene therapies for the treatment of a rare disease called sickle cell disease (SCD) in patients 12 years and older, is a huge development. With rare diseases posing significant challenges due to the scarcity of information, limited research, and insufficient awareness among healthcare professionals and the public, introduction and approval of specific treatments can provide a much needed boost to tackle the growing burden of rare diseases globally. However, an integrated approach with enhanced coordination and cooperation across the ecosystem is the need of the hour.
28th February, 2024
New Clinical AI care suites for Cardiology, Pulmonology, and Neurology; First-in-Class multi-modal predictive and Gen AI platform for research and clinical model development.
27th February, 2024
Bavarian Nordic is on track to submit its Marketing Authorisation Application for CHIKV VLP to EMA during H1 2024.
23rd February, 2024
Avanos Medical, Inc. Initiates Voluntary Recall Following Nurse Assist, LLC's Sterile Water Medical Products Recall
22nd February, 2024
First-ever installation in Fortis Hospital, Bengaluru
21st February, 2024
Introducing RetinAI Discovery® Platform and AI Tools for Enhanced Clinical Decision Making and Patient Management
20th February, 2024
Equipped with a 2D Fan Beam, the machine provides the highest image resolution for a precise diagnosis
13th February, 2024
This will enable Fresenius Medical Care to offer the industry-leading, high-volume hemodiafiltration (Hv-HDF) dialysis therapy – already widely used in Europe – for people living with kidney diseases in the U.S.
13th February, 2024
Jiva.ai and Aevice Health collaborate to pioneer breakthrough medical AI for asthma adverse event prediction based on Aevice Health’s FDA-cleared remote patient monitor.
06th February, 2024
CARDIOVIT® FT-2 is SCHILLER’s answer to the highest hospital demands. We are proud to announce our brand-new hospital ECG device CARDIOVIT® FT-2.
06th February, 2024
Terumo India, the Indian arm of Japan-based medtech firm Terumo Corporation, has recently announced the launch of new medical tools, intended for use in the management of liver cancer. With World Cancer Day, on February 4, 2024, calling to improve prevention, detection and treatment of cancer, new products are being launched in the Indian market to shape a way forward. MedTech Spectrum & BioSpectrum India spoke to Shishir Agarwal, President and Managing Director, Terumo India about the current scenario of the oncology medical devices market in the country.
02nd February, 2024
Transforming the Lives of 1 Lakh Preterm Infants in India through Innovative Healthcare Solutions
30th January, 2024
SBI General Insurance has embarked on a transformative journey in healthcare innovation by partnering with the Indian Institute of Technology Madras (IIT Madras) through the Corporate Social Responsibility (CSR) initiative. The program aims to empower the development of a Thermal Therapy Device, set to revolutionize the treatment landscape for breast cancer patients.
30th January, 2024
New analyzer complements hub labs by advancing capabilities of satellite and independent community hospital labs
30th January, 2024
Enhatch Inc. is excited to announce the U.S. Food and Drug Administration (FDA) 510(k) clearance of a patient specific instrumentation system for Total Knee Arthroplasty. This state-of-the-art system is redefining total knee arthroplasty with its AI-driven approach, encompassing both anatomic model generation and treatment planning
26th January, 2024
Collaboration with Kenya Ministry of Health National Cancer Institute Aims to Expand Access to Diagnostics, Reduce Cervical Cancer Rates
26th January, 2024
Olympus Strengthens its Medical Portfolio with Successful Acquisition of Taewoong Medical Co., Ltd, a Leading Korean Gastrointestinal Stent Company
24th January, 2024
© 2023 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer